• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脐静脉移植物中的生物降解与动脉瘤形成。观察结果及切实可行的策略。

Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy.

作者信息

Dardik H, Ibrahim I M, Sussman B, Kahn M, Sanchez M, Klausner S, Baier R E, Meyer A E, Dardik I I

出版信息

Ann Surg. 1984 Jan;199(1):61-8. doi: 10.1097/00000658-198401000-00011.

DOI:10.1097/00000658-198401000-00011
PMID:6691733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1353259/
Abstract

In a series of 756 glutaraldehyde-stabilized umbilical vein grafts implanted over a 7 1/2-year period, aneurysms were identified in seven cases. The earliest aneurysm was seen at 31 months after implantation and the remainder between 43 and 79 months after surgery. Corrective surgery was performed in five cases and succeeded in four. Although definite mechanisms have not been identified, mechanical fatigue, reversal of aldehyde crosslinks, and immunologic factors may be operative. The pathologic changes include: (1) actual dilation of both graft and mesh with or without intraluminal thrombus and, (2) maintenance of graft diameter with erosion of the umbilical vein and polyester mesh rupture leading to perigraft hematoma and false aneurysm formation. Microscopic examination and infrared spectral analysis confirmed the presence of host-contributed lipid in some specimens. Although this is a low incidence of aneurysm formation, umbilical vein grafts should be selected primarily for patients with limited life expectancy or for whom alternative materials with comparable or superior patency rates are not available or acceptable. Periodic angiography, particularly after 3 or 4 years, is recommended as a routine part of follow-up examinations. Improved graft materials and control of host environmental factors are potential means to reduce the noted degradation.

摘要

在7年半的时间里植入了一系列756个戊二醛固定的脐静脉移植物,其中7例发现有动脉瘤形成。最早的动脉瘤在植入后31个月出现,其余的在手术后43至79个月出现。5例患者接受了矫正手术,4例成功。虽然尚未确定确切机制,但机械疲劳、醛交联的逆转和免疫因素可能起作用。病理变化包括:(1)移植物和网片实际扩张,伴有或不伴有腔内血栓形成;(2)移植物直径保持不变,但脐静脉受侵蚀且聚酯网片破裂,导致移植物周围血肿和假性动脉瘤形成。显微镜检查和红外光谱分析证实部分标本中存在宿主来源的脂质。虽然动脉瘤形成的发生率较低,但脐静脉移植物应主要用于预期寿命有限的患者,或无法获得或无法接受具有相当或更高通畅率的替代材料的患者。建议定期进行血管造影,特别是在3或4年后,作为随访检查的常规部分。改进移植物材料和控制宿主环境因素是减少所述降解的潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/be70b128272d/annsurg00119-0077-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/d51f3c6cb3be/annsurg00119-0073-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/0b05dd92a4cf/annsurg00119-0074-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/390cb5613b91/annsurg00119-0075-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/8f99a1d2c02f/annsurg00119-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/2237aa544b40/annsurg00119-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/04c2265fc55b/annsurg00119-0077-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/be70b128272d/annsurg00119-0077-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/d51f3c6cb3be/annsurg00119-0073-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/0b05dd92a4cf/annsurg00119-0074-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/390cb5613b91/annsurg00119-0075-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/8f99a1d2c02f/annsurg00119-0076-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/2237aa544b40/annsurg00119-0076-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/04c2265fc55b/annsurg00119-0077-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e28a/1353259/be70b128272d/annsurg00119-0077-b.jpg

相似文献

1
Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy.脐静脉移植物中的生物降解与动脉瘤形成。观察结果及切实可行的策略。
Ann Surg. 1984 Jan;199(1):61-8. doi: 10.1097/00000658-198401000-00011.
2
Biodegradation of glutaraldehyde-tanned human umbilical vein grafts.戊二醛鞣制的人脐静脉移植物的生物降解
Surg Today. 1995;25(10):901-5. doi: 10.1007/BF00311756.
3
A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb.
J Vasc Surg. 1988 Feb;7(2):336-46. doi: 10.1067/mva.1988.avs0070336.
4
Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases.戊二醛鞣制人脐静脉移植物用于下肢血管重建的数十年比较经验:1275例分析
J Vasc Surg. 2002 Jan;35(1):64-71.
5
Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).采用戊二醛固定人脐静脉(HUV)的股腘人工血管搭桥术。
J Vasc Surg. 2007 Aug;46(2):280-8. doi: 10.1016/j.jvs.2007.03.054. Epub 2007 Jun 27.
6
Aneurysm formation in human umbilical vein grafts used as arterial substitutes.用作动脉替代物的人脐静脉移植物中的动脉瘤形成。
J Vasc Surg. 1985 Jul;2(4):524-9. doi: 10.1067/mva.1985.avs0020524.
7
A clinicopathologic study of aneurysm formation of glutaraldehyde-tanned human umbilical vein grafts.戊二醛鞣制的人脐静脉移植物动脉瘤形成的临床病理研究
J Vasc Surg. 1989 Dec;10(6):605-11. doi: 10.1067/mva.1989.14860.
8
Prediction of aneurysm formation in vascular grafts of biologic origin.
J Vasc Surg. 1988 Mar;7(3):400-8.
9
Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia.
Eur J Vasc Endovasc Surg. 2007 Nov;34(5):583-9. doi: 10.1016/j.ejvs.2007.04.010. Epub 2007 Jun 15.
10
Glutaraldehyde-stabilized umbilical vein prosthesis for revascularization of the legs. Three year results by life table analysis.用于腿部血管重建的戊二醛固定脐静脉假体。寿命表分析的三年结果。
Am J Surg. 1979 Aug;138(2):234-7. doi: 10.1016/0002-9610(79)90376-3.

引用本文的文献

1
Endovascular rescue of long-term vascular graft implants and need for continuous surveillance.长期血管移植物植入的血管内挽救及持续监测的必要性。
J Vasc Surg Cases Innov Tech. 2017 Dec 27;4(1):12-14. doi: 10.1016/j.jvscit.2017.09.004. eCollection 2018 Mar.
2
Human Perinatal-Derived Biomaterials.人围产期来源生物材料。
Adv Healthc Mater. 2017 Sep;6(18). doi: 10.1002/adhm.201700345. Epub 2017 Aug 7.
3
Stem cell sources for vascular tissue engineering and regeneration.用于血管组织工程和再生的干细胞来源。

本文引用的文献

1
Decreased hepatic copper levels. A possible chemical marker for the pathogenesis of aortic aneurysms in man.肝脏铜水平降低。人类主动脉瘤发病机制的一种可能化学标志物。
Arch Surg. 1982 Sep;117(9):1212-3. doi: 10.1001/archsurg.1982.01380330070017.
2
Revascularization of the femoropopliteal arteries using saphenous vein, polytetrafluoroethylene, and umbilical vein grafts. Five- and six-year results.使用大隐静脉、聚四氟乙烯和脐静脉移植物对股腘动脉进行血管重建。五年和六年的结果。
Arch Surg. 1982 Dec;117(12):1543-50. doi: 10.1001/archsurg.1982.01380360019005.
3
Technique of femoropopliteal and femorotibial grafts using umbilical vein.
Tissue Eng Part B Rev. 2012 Oct;18(5):405-25. doi: 10.1089/ten.TEB.2011.0264. Epub 2012 Jul 3.
4
Crosslinked urethane doped polyester biphasic scaffolds: Potential for in vivo vascular tissue engineering.交联型氨酯掺杂聚酯双相支架:用于体内血管组织工程的潜力。
J Biomed Mater Res A. 2010 Nov;95(2):361-70. doi: 10.1002/jbm.a.32846.
5
Modified vein allograft for small arterial reconstruction in dogs.改良静脉同种异体移植物用于犬小动脉重建
Jpn J Surg. 1986 May;16(3):225-30. doi: 10.1007/BF02471097.
6
Factors contributing to success and failure of femorotibial bypass grafts.影响股胫搭桥移植术成败的因素。
World J Surg. 1988 Dec;12(6):768-76. doi: 10.1007/BF01655479.
7
Mechanical properties and immunogenicity of vascular xenografts.
Jpn J Surg. 1991 Sep;21(5):533-41. doi: 10.1007/BF02470991.
使用脐静脉进行股腘动脉和股胫动脉移植的技术
Surg Gynecol Obstet. 1982 Aug;155(2):246-9.
4
Aneurysm formation in human umbilical vein grafts.
Surgery. 1982 Mar;91(3):343-5.
5
Objective analysis of factors contributing to failure of tibial bypass grafts.对导致胫动脉搭桥移植失败的因素进行客观分析。
World J Surg. 1983 May;7(3):347-52. doi: 10.1007/BF01658083.
6
Femoropopliteal bypass: the preferred site for distal anastomosis.股腘动脉搭桥术:远端吻合的首选部位。
Surgery. 1983 Jan;93(1 Pt 1):1-4.
7
Morphologic and biophysical assessment of long term human umbilical cord vein implants used as vascular conduits.用作血管导管的长期人类脐带静脉植入物的形态学和生物物理学评估。
Surg Gynecol Obstet. 1982 Jan;154(1):17-26.
8
Three-year experience with glutaraldehyde-stabilized umbilical vein for limb salvage.使用戊二醛固定脐静脉进行肢体挽救的三年经验。
Br J Surg. 1980 Apr;67(4):229-32. doi: 10.1002/bjs.1800670402.
9
Antigen depressant effect of glutaraldehyde for aortic heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts.戊二醛对带瓣主动脉异种移植物的抗原抑制作用,特别提及适合移植物保存的浓度
Surgery. 1980 Feb;87(2):170-6.
10
A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery. Preliminary results.聚四氟乙烯与人体脐静脉用于股腘动脉搭桥手术的随机临床试验。初步结果。
Br J Surg. 1983 Feb;70(2):85-8. doi: 10.1002/bjs.1800700210.